**Core Concept**
Subacute cutaneous lupus erythematosus (SCLE) is a subtype of cutaneous lupus erythematosus characterized by specific autoantibody production, primarily targeting the Ro/SS-A antigen. This autoantibody is associated with a distinct clinical presentation and often used as a diagnostic marker.

**Why the Correct Answer is Right**
The correct autoantibody for SCLE is Ro/SS-A. This autoantibody is directed against the Ro/SS-A ribonucleoprotein complex, which is a component of the spliceosome. The presence of anti-Ro/SS-A antibodies is highly suggestive of SCLE, as it is found in up to 97% of patients with this condition. The pathogenesis of SCLE involves the deposition of immune complexes containing anti-Ro/SS-A antibodies in the skin, leading to inflammation and skin lesions.

**Why Each Wrong Option is Incorrect**
* **Option A:** Anti-Sm antibodies are more commonly associated with systemic lupus erythematosus (SLE) and are not specific to SCLE.
* **Option B:** Anti-Ro/SS-B antibodies are also found in SLE, but are not as specific to SCLE as anti-Ro/SS-A antibodies.
* **Option D:** Anti-SS-A antibodies are a synonym for anti-Ro/SS-A antibodies, but the question is specifically asking for the most suggestive autoantibody, which is anti-Ro/SS-A.

**Clinical Pearl / High-Yield Fact**
Remember that anti-Ro/SS-A antibodies are not only associated with SCLE but also with congenital heart block and neonatal lupus.

**Correct Answer: C. Ro/SS-A**